Case Summary. Workshop Overview. Mr. M

Size: px
Start display at page:

Download "Case Summary. Workshop Overview. Mr. M"

Transcription

1 9:00 10:30 Workshop Overview Mr. M Who is this document primarily intended to reach? What is the format? How soon should I see a newly referred heart failure patient? How often should my heart failure patient be seen? Who can I discharge from my heart failure clinic? How quickly and in what order should standard heart failure therapy be titrated for most patients? When should I measure electrolytes, serum Creatinine and BUN? How should I manage hyper or hypokalemia in my patients? I know I should get a baseline measure of left ventricular ejection fraction- but should I measure it again? If so, when should it be measured? Can heart failure medications ever be stopped? If so, then when? How should I manage an acute episode of gout? In what ways do I care differently for frail elderly patients with heart failure? How do I teach self- care to my patients? 71 year old man with an ischemic cardiomyopathy. NYHA III, LVEF 30% COPD, diabetes, chronic renal failure, atrial fibrillation Takes 12 different types of medications daily (blister pack) Lives alone in an apartment- 4 admissions for heart failure in the past year Mrs. Tetley ID: 85 yr female referred from GP for new onset HF HPI: 3/12 progressive SOBOE, 2+bilateral pitting edema, nocturnal cough, 2 pillow orthopnea. GP started furosemide 2 weeks ago; SOBOE improved and orthopnea resolved. PMHx: o HTN (x 30 years, well controlled) o DM (x 15 years, diet controlled) o Atrial fibrillation (x 5 years) o GERD/PUD (UGIB x 3 years ago) o OA

2 9:00 10:30 Medications: HF: Furosemide 40mg daily (started 2 weeks ago) HTN: HCTZ 25 mg daily, Potassium chloride 20MEq daily, Amlodipine 5mg daily, ECASA 81mg daily DM: Diet controlled, Rosuvastatin 10mg daily Atrial Fibrillation: Metoprolol 25mg BID, Dabigatran 150mg BID GERD/PUD: Pantoprazole 40 mg daily OA: OTC: Naproxen 220mg daily Vitamin D 2000IU daily, Calcium 1500mg daily, multivitamin daily, Vitamin E 800IU daily, Vitamin C 1000mg daily, Vitamin B Complex 50mcg daily Investigations: Echo: LV dilation, dilated LA, EF = 40%, diastolic dysfunction, aortic sclerosis MIBI: normal perfusion ECG: atrial fibrillation, HR = 68bpm CXR: mild pulmonary edema Labs: Scr = 100umol/L; K = 4.8 mmol/l; Na = 135mmol/L Weight = 40kg BP = 114/68 mmhg sitting; 110/60 standing CVS Exam = JVP 5cm ASA; Bilateral crackles; II/IV MSM; 2+bilateral pitting edema to mid- shin Q1. Plan? Furosemide (Options: increase, decrease, maintain) Q2. Plan? Metoprolol (Options: increase, decrease, maintain, discontinue) Q3. Plan? ACEI (Options: yes, no) Q3. Plan? Other medications (Options: stop amlodipine, stop HCTZ, stop potassium, stop ASA, stop vitamins, stop naproxen, all the above) Additional Information: Baseline Scr = 40umol/L = CrCl 68ml/min Current Scr = 100umol/L = CrCl 27ml/min Q4. Does this change your plan? (Options: yes, no) Additional Information: Baseline K = 3.2mmol/L

3 9:00 10:30 Current K = 4.8mmol/L Q5. Does this change your plan? (Options: yes, no) Follow- up via telephone (1 week later): Furosemide and metoprolol were maintained and ramipril 1.25mg BID was started; other medications were streamlined She reports feeling better, but still has some SOBOE and mild peripheral edema Blood work done the day prior reveals: o SCr = 101 umol/l (was 100umol/L) o K = 5.5 mmol/l (was 4.8 umol/l) Q5. What is your plan? (Options: hold ACEI repeat BW in 3-5 days), hold ACEI and give sodium polysterene (Kayexalate ) (repeat BW in 2 days), assess dietary intake (ensure K+ supplement was discontinued) (repeat BW in 5-7days)) Mrs. Doe Diagnosed with pre- ecclampsia at 24 weeks Progressive edema Went into labour at 34 weeks o Pulmonary edema day 2 post natal o Nearly intubated ECHO: LV 57 mm (EDD), EF 18%, moderate MR She was treated with vasodilators and diuretics Improved ACE and BB started Tolerated, titrated Clinical improvement Follow- up: Now asymptomatic Diuretic stopped due to hypovolemia Repeat ECHO EF 54% o LV EDD 48 mm o No MR o Normal RVSP est but only trivial TR

4 9:00 10:30 Q1. She would like to stop her medications. (Options: yes, no) If yes, which medications? Case 4 74 yo male with 10 year hx DCM (normal coronaries), followed in HF clinic ICD inserted 6 years ago Has done very well since you have seen him Perindopril 8 mg OD Digoxin mg OD Carvedilol 25 mg BID Spironolactone 25 mg OD Lasix 40 mg OD- patient has not been taking it BP 120/70, HR 60 reg JVP ASA, - AJR HS: S1, S2, no murmurs, no rub 1+ pretibial edema bilaterally No palpable organomegaly Chest: clear Hb 128, WBC 6.5 (n diff) Na 139, K 4.7, creat 100 LVEF 54% and LVID 55 mm o Had been 23% and 64 mm 3 years ago Q1. Would you stop his medications? (Options: yes, no, it depends) Q1. Would you replace his ICD? (Options: yes, no, leave it to EP, it depends) Case 5 39 y.o. male Seen last year with A Flutter and LVEF 22% o Was drinking heavily at time and was hypertensive Cardioverted and in NSR since then Now LVEF on ACE and BB and OAC is 60% Asymptomatic Q1. Do you stop his medications? (Options: yes, no, it depends) Follow- up:

5 9:00 10:30 Patient still drinking 2 drinks per day (what he admits to) Patient has gained 30 lbs (salesman, travel) and BP is elevated 150/94 Patients has developed diabetes during the past year Mrs. PP 60 year old female presented 1 year ago with breat cancer, HER + Underwent FAC and Trastuzamab therapy for 6 months 9 month EF showed EF 60 to 44% Trastuzamab stopped Progressive heart failure 3 months later Placed on Ace and BB and diuretic and Trastuzamab stopped Q1. Would you stop trastuzamab for good? (Options: yes, no) Q2. When would you re- check LVEF? (Options: yes, no) Follow- up: 3 months later LVEF is 55% on therapy Q3. Do you stop therapy? (Options: yes, no) Why or why not? Q4. How long would you follow if EF stayed normal? Mr. CC 62 year old man- presents to ER: 4 week history of increasing SOB, 3 pillow orthopnea, PND PMHx- viral cardiomyopathy (8 years ago) EF 35%, NYHA class I symptoms (until recently) Hypertension, family history CAD, non- smoker, rare ETOH, no diabetes, lipids normal Normal coronaries coronary angiogram 8 years ago Medications: Ramipril 12.5 mg daily, metoprolol 25 mg BID (not taking these for a few months- Weight: Kg BP 159/96 mm Hg ECG: Sinus rhythm- 80 bpm (narrow QRS) Lab: Creatinine 110umol/L, urea 9.2mmol/L, K+4.3 mmol/l, Na+140mmol/L

6 9:00 10:30 CXR: mild pulmonary edema Echo: global hypokinesis, EF 15%, no significant valvular abnormalities, RVSP 54 mm Hg. Dilated LA, RA, LV Q1. How would you optimize the pharmacological management for this patient? Q2. Does he need to be followed in a heart function clinic? Q3. How do you work through adherence issues? Q4. Does he need an ICD? Progress over next 2 years: Followed in HFC- optimization No hospitalizations NYHA Class I within 6 months o Optimized medications o Working through challenges with adherence * trust, negotiation o Sleep clinic assessment o Developed atrial fibrillation o No ICD Medications Atacand 32 mg OD Coreg 37.5 mg BID Lasix 40 mg prn- rarely uses Norvasc 2.5 mg OD Pradaxa 110 mg BID Other Weight: 100 Kg BP 124/82 mm Hg ECG- Afib 72bpm Echo: global HK- EF 35-40%. No valvular abnormalities, RVSP <35mmHg RNA- EF 34% Case 8 78 year old lady with a history of mildly obstructive cardiomyopathy for the past 30 years

7 9:00 10:30 Very stable on diltiazem 180 mg daily Lives with husband and used to walk everyday No history of CAD Over the past 2 years, developed shortness of breath on exertion and palpitations, also presents occasional dizziness Referred for evaluation at CHF clinic PEx: JVP 15, irregular HR 80/ min, loud systolic murmur of aortic stenosis, no S3, mild hepatomegaly and no pedal edema. ECG Afib and LVH Echo small LV with asymmetric hypertrophy and normal LVEF Severe calcified aortic stenosis Grad 80/45 with very small LVOT, very calcified mitral annulus with 20/10 gradients and severe LA dilatation No significant MR Moderate TR with PA pressure 50 mmhg +JVP Q1. What is your plan? (Options: anticoagulation and cardioversion, diuretics, change cardizem for B blocker, cardiac cath with intended surgery, keep in CHF clinic)

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?

Case 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized? Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising

More information

ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication Initiation and Titration

ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication Initiation and Titration ARNI (Angiotensin Receptor blocker / Neprilysin Inhibitors [Sacubutril/Valsartan]) Heart Failure Medication and Symptomatic HF despite ACEI/ARB and B-blocker therapy Bilateral renal artery stenosis Moderate/Severe

More information

Difficult to Treat Hypertension

Difficult to Treat Hypertension Difficult to Treat Hypertension According to Goldilocks JNC 8 Blood Pressure Goals (2014) BP Goal 60 years old and greater*- systolic < 150 and diastolic < 90. (Grade A)** BP Goal 18-59 years old* diastolic

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

Heart Failure Clinician Guide JANUARY 2018

Heart Failure Clinician Guide JANUARY 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.

More information

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated) Professor Ralph Stewart Cardiologist Auckland City Hospital Green Lane Cardiovascular Research Unit Auckland Heart Group Fiona Stewart Cardiologist Green Lane Hospital National Women's Hospital Professor

More information

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. 1 Phar6122: CV section Date: 3/21/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Heart Failure: Current Management Strategies

Heart Failure: Current Management Strategies Heart Failure: Current Management Strategies CSHP Fall Education Session- September 30th, 2017 Carolyn MacKinnon & Tamara Matchett BscPharm, ACPR Candidates Objectives 1. Describe the pathophysiology &

More information

5AB Dysrhythmia Interpretation and Management 2016

5AB Dysrhythmia Interpretation and Management 2016 5AB Dysrhythmia Interpretation and Management 2016 How to complete your biennial ECG review: A website has been created that contains the basic review information. Use this as a reference during your review.

More information

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management

AF in the ER: Common Scenarios CASE 1. Fast facts. Diagnosis. Management AF in the ER: Common Scenarios Atrial fibrillation is a common problem with a wide spectrum of presentations. Below are five common emergency room scenarios and the management strategies for each. Evan

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture.

Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. 1 Phar6122: CV section Date: 3/10/05 Topic: Chronic Heart Failure Cases for Monday s March 21th lecture. Directions: This handout includes three chronic heart failure cases of increasing difficulty. In

More information

A patient with decompensated HF

A patient with decompensated HF A patient with decompensated HF Professor Michel KOMAJDA University Pierre & Marie Curie Pitie Salpetriere Hospital Department of Cardiology Paris (France) Declaration Of Interest 2010 Speaker : Servier,

More information

2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much?

2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much? 2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much? Dr. Shelley Zieroth University of Manitoba @ShelleyZieroth @CanHFSociety Disclosures Consulting/Advisory Board: Amgen, Astra

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death Why guess when you could know? Gold Standard Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death PCI decisions Number of vessels involved Surgeon experience level The anatomic

More information

HEART FAILURE. Study day November 2018 Sarah Briggs

HEART FAILURE. Study day November 2018 Sarah Briggs HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure

More information

HEART FAILURE: PHARMACOTHERAPY UPDATE

HEART FAILURE: PHARMACOTHERAPY UPDATE HEART FAILURE: PHARMACOTHERAPY UPDATE 3 HEART FAILURE REVIEW 1 5.1 million x1.25 = 6.375 million 40 years old = MICHAEL F. AKERS, PHARM.D. CLINICAL PHARMACIST CENTRACARE HEALTH, ST. CLOUD HOSPITAL HF Diagnosis

More information

Management Strategies for Advanced Heart Failure

Management Strategies for Advanced Heart Failure Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology

More information

Mechanical versus bioprosthetic valve. Intern: Supervisor: VS

Mechanical versus bioprosthetic valve. Intern: Supervisor: VS Mechanical versus bioprosthetic valve Intern: Supervisor: VS Patient basic data ID: N102110716 Name: Age: 64 years old Sex: male Occupation: Admission date: 0960528 Chief complaint Exertional dyspnea for

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Vitals HR 90 BP 125/58 Tmax 98.7F O2 Sat 97% on NC 2L/min BMP SCr 1.78 K 3.9 Gluc 194 A1c 7.5 Cardiac LVEF 55% NTproBNP 9,200 Troponin 0.

Vitals HR 90 BP 125/58 Tmax 98.7F O2 Sat 97% on NC 2L/min BMP SCr 1.78 K 3.9 Gluc 194 A1c 7.5 Cardiac LVEF 55% NTproBNP 9,200 Troponin 0. ALDOSTERONE ANTAGONIST IN HEART FAILURE WITH PRESERVED EJECTION FRACTION ABBREVIATIONS BMP: basic metabolic panel HPI: history of present illness CAD: coronary artery disease HR: heart rate PINHUI (JUDY)

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib

Cost and Prevalence of A fib. Atrial Fibrillation: Guideline Directed Treatment. Prevalence of A Fib. Risk Factors for A Fib. Risk Factors for A Fib Atrial Fibrillation: Guideline Directed Treatment Melissa Wendell, FNP-C, MSN Heart Failure - Lead Nurse Practitioner, Aspirus Wausau Hospital and Aspirus Cardiology Cost and Prevalence of A fib 33.5 million

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

NEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology

NEWLY DETECTED ATRIAL FIBRILLATION. Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology NEWLY DETECTED ATRIAL FIBRILLATION Edgar S. Carell, M.D. Director, Vascular Medicine Clinic West Suburban Cardiology 68 y/o woman complains of - generalized fatigue - mild DOE - never eats but keeps gaining

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise

More information

Therapeutic Targets and Interventions

Therapeutic Targets and Interventions Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium

More information

Case based learning: CMR in Heart Failure

Case based learning: CMR in Heart Failure Case based learning: CMR in Heart Failure Milind Y Desai, MD FACC FAHA FESC Associate Professor of Medicine Heart and Vascular Institute, Cleveland Clinic Cleveland, OH Disclosures: none Use of Gadolinium

More information

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months Case 1 March 2016 59 yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months PMH diabetes, celiac disease Reports chest discomfort, positional coughing and pedal edema last 10

More information

Heart Failure A Disease for the Internist?

Heart Failure A Disease for the Internist? Heart Failure A Disease for the Internist? Dr Chris Davidson Sussex Cardiac Centre BRIGHTON UK Hot Topics in Heart Failure Drug treatments Valsartan / neprilysin inhib Investigations BNP and others Devices

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

Central Sleep Apnea Problem Based Learning Module

Central Sleep Apnea Problem Based Learning Module Central Sleep Apnea Problem Based Learning Module Vidya Krishnan, and Sutapa Mukherjee for the Sleep Education for Pulmonary Fellows and Practitioners, SRN ATS Committee 2015 Case Section I A 75 year old

More information

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has

More information

Heart Failure Update. Bibiana Cujec MD May 2015

Heart Failure Update. Bibiana Cujec MD May 2015 Heart Failure Update Bibiana Cujec MD May 2015 Disclosures Participation in clinical trial GUIDE IT (BNP in management of HF) Plan Review of new trials/ccs guidelines Management of heart failure: cases

More information

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Cardiology. Final Written Examination 2019

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Cardiology. Final Written Examination 2019 SAUDI FELLOWSHIP TRAINING PROGRAM Adult Cardiology Final Written Examination 2019 Objectives 1. Determine the trainee has sufficient competency related to the required specialty. 2. Determine the eligibility

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER ICD for NICM All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, 2017 2017 MFMER 3686275-1 DISCLOSURE Relevant Financial Relationship(s)

More information

NT-proBNP: Evidence-based application in primary care

NT-proBNP: Evidence-based application in primary care NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem

More information

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014 HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading

More information

Focus on Rehabilitation, Exercise and Surgical Coronary Revascularization

Focus on Rehabilitation, Exercise and Surgical Coronary Revascularization Focus on Rehabilitation, Exercise and Surgical Coronary Revascularization Sam Haddad, MD Kenneth O Reilly, MD Disclosure of Commercial or Pharma Support NTD Learning Objectives At the conclusion of this

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

The CCS Heart Failure Companion: Bridging Guidelines to your Practice

The CCS Heart Failure Companion: Bridging Guidelines to your Practice The CCS Heart Failure Companion: Bridging Guidelines to your Practice Looking for practical answers concerning optimal heart failure care? The CCS Heart Failure Guidelines Companion can help. The Canadian

More information

Susan P. D Anna MSN, APRN BC February 14, 2019

Susan P. D Anna MSN, APRN BC February 14, 2019 Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with

More information

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology

Chronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center

More information

Case Discussion. 18 th Annual UCSD Heart Failure Symposium

Case Discussion. 18 th Annual UCSD Heart Failure Symposium Case Discussion 18 th Annual UCSD Heart Failure Symposium In your office today is a returning patient and an eager-to-please 3 rd year medical student. You review HF s history as the student is in the

More information

SUPPLEMENTAL MATERIAL

SUPPLEMENTAL MATERIAL SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations

New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations New Concepts in Acute Coronary Syndromes Beyond 2000 (XX) Interactive Case Presentations Dr. Richard Bon Surrey Memorial Hospital, Surrey, BC Canadian Cardiovascular Congress 2014 October 26, 2014 Conflicts

More information

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Tachycardias Case #1 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136 Initial Assessment Check Telemetry screen if pt on tele Telemetry

More information

HEART FAILURE. Ali Mehr, MD, FACC

HEART FAILURE. Ali Mehr, MD, FACC HEART FAILURE Ali Mehr, MD, FACC Advanced Heart Failure and Transplant Cardiologist Director, Echocardiography Lab Phoenix VA Health Care System Associate Professor of Medicine University of Arizona, COM,

More information

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness

More information

MEDICAL MANAGEMENT OF PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

MEDICAL MANAGEMENT OF PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION MEDICAL MANAGEMENT OF PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION FRANCIS X. CELIS, D.O. OPSO FALL CONFERENCE PORTLAND, OR 16 SEPTEMBER 2017 OVERVIEW What are the ACC/AHA Stages of HF? What

More information

5/5/2010. World incidence 720, 000 new cases / year. World prevalence 5.55 million AF prevalence increasing with aging of population

5/5/2010. World incidence 720, 000 new cases / year. World prevalence 5.55 million AF prevalence increasing with aging of population Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Samy Claude ELAYI Cardiac Clinical Pacing and Electrophysiology UK World incidence 720, 000 new cases / year World prevalence 5.55

More information

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities

More information

Heart Failure New Drugs- Updated Guidelines

Heart Failure New Drugs- Updated Guidelines Heart Failure New Drugs- Updated Guidelines Eileen Handberg, PhD, ANP-BC, FAHA, FACC Professor of Medicine Division of Cardiovascular Medicine University of Florida Disclosures 1. 3 2. 6 3. 8 4. 11 Dunlay

More information

Atrial Fibrillation: Guidelines through clinical cases and 2010 updates

Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Samy Claude ELAYI Cardiac Clinical Pacing and Electrophysiology World incidence 720, 000 new cases / year World prevalence 5.5 million

More information

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR William A. Zoghbi MD, FASE, MACC Professor and

More information

Valvular Heart Disease Mitral Stenosis

Valvular Heart Disease Mitral Stenosis Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema

More information

Heart Failure. Jay Shavadia

Heart Failure. Jay Shavadia Heart Failure Jay Shavadia Definition Clinical syndrome characterized by: Symptoms: breathlessness at rest or on exercise, fatigue, tiredness or ankle swelling AND Signs: tachycardia, tachypnea, pulmonary

More information

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018 Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%

More information

CASE STUDIES IN ADVANCED HEART FAILURE

CASE STUDIES IN ADVANCED HEART FAILURE CASE STUDIES IN ADVANCED HEART FAILURE Navin Rajagopalan, MD Director, Congestive Heart Failure Medical Director, Cardiac Transplantation Gill Heart Institute, Cardiovascular Medicine DISCLOSURES NOTHING

More information

Heart Failure Update John Coyle, M.D.

Heart Failure Update John Coyle, M.D. Heart Failure Update 2011 John Coyle, M.D. Causes of Heart Failure Anderson,B.Am Heart J 1993;126:632-40 It It is now well-established that at least one-half of the patients presenting with symptoms and

More information

Medical Apps for Cardiology Uses. There s an App for That!

Medical Apps for Cardiology Uses. There s an App for That! Medical Apps for Cardiology Uses There s an App for That! Audience Participation Question #1 1. ASCVD Risk App What is the predicted 10 year CV event rate for a 57 y/o black male patient with treated

More information

Case based learning: CMR in Heart Failure

Case based learning: CMR in Heart Failure Case based learning: CMR in Heart Failure Milind Y Desai, MD FACC FAHA FESC Associate Professor of Medicine Heart and Vascular Institute, Cleveland Clinic Cleveland, OH Disclosures: none Use of Gadolinium

More information

The Failing Heart in Primary Care

The Failing Heart in Primary Care The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and

More information

Controversies in Atrial Fibrillation and HF

Controversies in Atrial Fibrillation and HF Controversies in Atrial Fibrillation and HF Dr.Yahya Al Hebaishi Cardiac electrophysiology division, PSCC, Riyadh Atrial Fibrillation: Rate or Rhythm? HF and AF: the twin epidemic of cardiovascular disease.

More information

Heart Failure: Guideline-Directed Management and Therapy

Heart Failure: Guideline-Directed Management and Therapy Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the

More information

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Pharmacotherapy: A Practical Approach Hypertension Pharmacotherapy: A Practical Approach Ronald Victor, MD Burns & Allen Chair in Cardiology Director, The Hypertension Center Associate Director, The Heart Institute Hypertension Center 1. 2.

More information

Update in Congestive Hear Failure DRAGOS VESBIANU MD

Update in Congestive Hear Failure DRAGOS VESBIANU MD Update in Congestive Hear Failure DRAGOS VESBIANU MD Case 58 yo AAM c/o shortness of breath for 3 weeks. Used to walk one mile per day and now he has noticed that he gets short of breath after 2 blocks.

More information

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty

More information

CHF ICU to community. Disclosure slide CHF. Diagnosis. Diagnosis. Diagnostic modalties Therapeutic modalities. Talks. Advisory boards.

CHF ICU to community. Disclosure slide CHF. Diagnosis. Diagnosis. Diagnostic modalties Therapeutic modalities. Talks. Advisory boards. CHF ICU to community CHF Diagnostic modalties Therapeutic modalities ICU Pacer/ ICD Medication CHF clinic ASV - Nejm. Sept. 17,2015. Advanced care directives Disclosure slide Talks most companies Advisory

More information

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

More information

UBMD Internal Medicine

UBMD Internal Medicine UBMD Internal Medicine Clinical Documentation Example Established Outpatient Visit - 99215 Pat Kisiel-Neunder, Compliance Administrator Email: pkisieln@buffalo.edu Regulations The following information

More information

Advanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary

Advanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Advanced Heart Failure Management Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary Grading of heart failure Mr WY age 73 3/12 dyspnoea, fatigue and some ankle oedema PMH: hypertension

More information

#1 Current Problem: Recurrent Hemoptysis, getting progressively worse

#1 Current Problem: Recurrent Hemoptysis, getting progressively worse Brief Patient Summary/ Octavia Helios DOB 1/2/45 MRN# A212222 As of 2/2/07 #1 Current Problem: Recurrent Hemoptysis, getting progressively worse HPI: Mrs. H. has developed hemoptysis over the past 3 months,

More information

Cardiovascular Clinical Practice Guideline Pilot Implementation

Cardiovascular Clinical Practice Guideline Pilot Implementation Cardiovascular Clinical Practice Guideline Pilot Implementation Pharmacologic Management of Chronic Heart Failure Sept 15, 2004 Angela Allerman, PharmD, BCPS DoD Pharmacoeconomic Center Promoting high

More information

Contemporary Management of Heart Failure. Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium

Contemporary Management of Heart Failure. Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium Contemporary Management of Heart Failure Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium Disclosures I have no relevant relationships with commercial

More information

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 10/5/2015. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 10/5/2015. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading DRG among

More information

LITERATURE REVIEW: HEART FAILURE. Chief Residents

LITERATURE REVIEW: HEART FAILURE. Chief Residents LITERATURE REVIEW: HEART FAILURE Chief Residents Heart Failure EF 40% HFrEF Problem with contractility EF 40-50% HFmrEF EF > 50% HFpEF Problem with filling/relaxation RISK FACTORS Post MI HTN DM Obesity

More information

Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new

Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new B. Sonnenberg UAH Cardiology CME Day 5 May 2015 Disclosures Speaker s or Advisory Boards: none Research grants: none (co-investigator

More information

Heart Failure: Combination Treatment Strategies

Heart Failure: Combination Treatment Strategies Heart Failure: Combination Treatment Strategies M. McDonald MD, FRCP State of the Heart Symposium May 28, 2011 None Disclosures Case 69 F, prior MIs (LV ejection fraction 25%), HTN No demonstrable ischemia

More information

Management of Elderly CAD Patients with Multiple Morbidities

Management of Elderly CAD Patients with Multiple Morbidities Management of Elderly CAD Patients with Multiple Morbidities 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any

More information

Chronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH

Chronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center

More information

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which

More information

Pericardial Disease: Case Examples. Echo Fiesta 2017

Pericardial Disease: Case Examples. Echo Fiesta 2017 Pericardial Disease: Case Examples Echo Fiesta 2017 2014 2014 MFMER MFMER 3346252-1 slide-1 Objectives Have a systematic approach to evaluation of constriction 2014 MFMER 3346252-2 CASE 1 2013 MFMER 3248567-3

More information

The NEW Heart Failure Guidelines

The NEW Heart Failure Guidelines The NEW Heart Failure Guidelines Daily Practice HF scenario of the Case Presentations HF as a complex and heterogeneous syndrome Several proposed pathophysiological mechanisms involving the heart and the

More information

Cardiomyopathy: The Good, the Bad.and the Insurable?

Cardiomyopathy: The Good, the Bad.and the Insurable? Cardiomyopathy: The Good, the Bad.and the Insurable? WAHLU Spring Seminar 2014 Joy Geiger, RN, BSN, ALMI Medical Consultant The Northwestern Mutual Life Insurance Company Milwaukee, WI Objectives Overview

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014

More information

More acute cardiology

More acute cardiology Case 1 RC 86, Male More acute cardiology Dr John Chambers Consultant Cardiologist A&E: SOB at rest. No chest pain. Exertional SOB for 6/12. PMHx: HT Rx: Ramipril 5mg od Examination: Afebrile, HR = 105,

More information

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION

ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION ATRIAL FIBRILLATION: REVISITING CONTROVERSIES IN AN ERA OF INNOVATION Frederick Schaller, DO, MACOI,FACP Adjunct Clinical Professor Touro University Nevada DISCLOSURES I have no financial relationships

More information

Clinical Case. Female, 62 years January 2016

Clinical Case. Female, 62 years January 2016 Clinical Case Female, 62 years January 2016 Dr. Ramón Corbalán H. Facultad de Medicina División de Enfermedades Cardiovasculares Pontificia Universidad Católica de Chile Clinical Hx Background: Ostheoartritis

More information

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography

Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Evaluation of a diagnostic pathway in heart failure in primary care, using electrocardiography and brain natriuretic peptide guided echocardiography Rebecka Karlsson Pardeep Jhund 1 Material and methods

More information

Fibs and Flutters: The Heart of the Matter

Fibs and Flutters: The Heart of the Matter Fibs and Flutters: The Heart of the Matter Anita Ralstin, CNP By the Numbers Atrial Fibrillation Hospital Discharges /quarter for 2012 -- 116,500 Average Length of Stay 4 days Projected that 20% of those

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU Management of acute decompensated heart failure and cardiogenic shock Arintaya Phrommintikul Department of Medicine CMU Acute heart failure: spectrum Case 64 y/o M with Hx of non-ischemic DCM (LVEF=25-30%)

More information

SGK 2016 Session: Postgraduate Course in Heart Failure Lausanne, 15. June 2016 Heart Failure Guidelines 2016

SGK 2016 Session: Postgraduate Course in Heart Failure Lausanne, 15. June 2016 Heart Failure Guidelines 2016 SGK 2016 Session: Postgraduate Course in Heart Failure Lausanne, 15. June 2016 Heart Failure Guidelines 2016 Matthias Nägele, MD University Hospital Zurich Disclosures I have nothing to disclose. The new

More information